World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
72
Citations
24099
World Ranking
6175
National Ranking
471

Rab K. Prinjha publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Rab K. Prinjha sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 200 publications — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Rab K. Prinjha D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Rab K. Prinjha sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 72 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Rab K. Prinjha is affiliated with GlaxoSmithKline in the United Kingdom. Their research primarily spans the fields of Biochemistry, Genetics and Molecular Biology, and Medicine. Within these broader fields, Prinjha's work has focused extensively on Molecular Biology, Hematology, Immunology, Virology, and Epidemiology.

The scientist's main research topics include Protein Degradation and Inhibitors, Multiple Myeloma Research and Treatments, Ubiquitin and proteasome pathways, Histone Deacetylase Inhibitors Research, HIV Research and Treatment, Epigenetics and DNA Methylation, and Immune cells in cancer.

Several recent papers illustrate the scope of Prinjha's research contributions:

  • "Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation," 2020, Science
  • "Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia," 2021, Nature Cancer
  • "Histone H3K27me3 demethylases regulate human Th17 cell development and effector functions by impacting on metabolism," 2020, Proceedings of the National Academy of Sciences
  • "GSK789: A Selective Inhibitor of the First Bromodomains (BD1) of the Bromo and Extra Terminal Domain (BET) Proteins," 2020, Journal of Medicinal Chemistry
  • "Discovery of a Bromodomain and Extraterminal Inhibitor with a Low Predicted Human Dose through Synergistic Use of Encoded Library Technology and Fragment Screening," 2020, Journal of Medicinal Chemistry

Frequent co-authors in Prinjha's publications include Inmaculada Rioja, Chun-wa Chung, Paul Bamborough, Emmanuel H. Demont, and Paola Grandi. These collaborations highlight sustained partnerships in producing research within their areas of study.

The venues where Prinjha has published most frequently consist of:

  • Journal of Medicinal Chemistry
  • bioRxiv (Cold Spring Harbor Laboratory)
  • ACS Medicinal Chemistry Letters
  • SSRN Electronic Journal
  • Proceedings of the National Academy of Sciences

Best Publications

  • Suppression of inflammation by a synthetic histone mimic

    Edwige Nicodeme;Kate L. Jeffrey;Uwe Schaefer;Soren Beinke

  • Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia

    Mark A. Dawson;Rab K. Prinjha;Antje Dittmann;George Giotopoulos

  • Identification of miRNA Changes in Alzheimer's Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways

    John P. Cogswell;James Ward;Ian A. Taylor;Michelle Waters

  • Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation

    Huw D Lewis;John Liddle;Jim E Coote;Stephen J Atkinson

  • Remodeling of the Enhancer Landscape during Macrophage Activation Is Coupled to Enhancer Transcription

    Minna U. Kaikkonen;Nathanael J. Spann;Sven Heinz;Casey E. Romanoski

  • Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease

    Hao Li;Sally Wetten;Li Li;Pamela L. St. Jean

  • Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis

    Sergio E. Baranzini;Joanne Wang;Rachel A. Gibson;Nicholas Galwey

  • Neuropilin-2 Is Required In Vivo for Selective Axon Guidance Responses to Secreted Semaphorins

    Roman J. Giger;Jean François Cloutier;Amar Sahay;Rabinder K. Prinjha

  • BET inhibitor resistance emerges from leukaemia stem cells

    Chun Yew Fong;Omer Gilan;Omer Gilan;Enid Y N Lam;Alan Rubin

  • An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer

    Marian L. Burr;Marian L. Burr;Marian L. Burr;Christina E. Sparbier;Christina E. Sparbier;Kah Lok Chan;Kah Lok Chan;Yih-Chih Chan

  • Broadly Neutralizing Antibodies and Viral Inducers Decrease Rebound from HIV-1 Latent Reservoirs in Humanized Mice

    Ariel Halper-Stromberg;Ching-Lan Lu;Florian Klein;Joshua A. Horwitz

  • Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation

    Omer Gilan;Omer Gilan;Inmaculada Rioja;Kathy Knezevic;Matthew J. Bell

  • Discovery and Characterization of Small Molecule Inhibitors of the Bet Family Bromodomains.

    Chun-wa Chung;Hervé Coste;Julia H. White;Olivier Mirguet

  • Cloning and functional expression of a human orthologue of rat vanilloid receptor-1.

    Philip Hayes;Helen J Meadows;Martin J Gunthorpe;Mark H Harries

  • Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia

    Panagiotis Ntziachristos;Panagiotis Ntziachristos;Aristotelis Tsirigos;G. Grant Welstead;Thomas Trimarchi

  • Suppression of the antiviral response by an influenza histone mimic

    Ivan Marazzi;Jessica S. Y. Ho;Jaehoon Kim;Balaji Manicassamy

  • Discovery of Epigenetic Regulator I-BET762: Lead Optimization to Afford a Clinical Candidate Inhibitor of the BET Bromodomains

    Olivier Mirguet;Romain Gosmini;Jérôme Toum;Catherine A. Clément

  • Identification of a Novel Series of Bet Family Bromodomain Inhibitors: Binding Mode and Profile of I-Bet151 (Gsk1210151A).

    Jonathan Seal;Yann Lamotte;Frédéric Donche;Anne Bouillot

  • Lysine methylation of the NF-κB subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NF-κB signaling

    Dan Levy;Alex J Kuo;Yanqi Chang;Uwe Schaefer

  • Place your BETs: the therapeutic potential of bromodomains

    R.K. Prinjha;J. Witherington;K. Lee

Frequent Co-Authors

Chun-wa Chung
Chun-wa Chung GlaxoSmithKline (United Kingdom)
David F. Tough
David F. Tough GlaxoSmithKline (United Kingdom)
Mark A. Dawson
Mark A. Dawson Peter MacCallum Cancer Centre
Alexander Tarakhovsky
Alexander Tarakhovsky Rockefeller University
Gerard Drewes
Gerard Drewes GlaxoSmithKline (United Kingdom)
Tony Kouzarides
Tony Kouzarides University of Cambridge
Udo Oppermann
Udo Oppermann University of Oxford
Susanne Müller
Susanne Müller Structural Genomics Consortium
Paul P. Tak
Paul P. Tak GlaxoSmithKline (United Kingdom)
Marcus Bantscheff
Marcus Bantscheff GlaxoSmithKline (United Kingdom)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Rab K. Prinjha

Trending Scientists

Recently Published Articles